Skip to content

Clinical trials

Completed Breast Neoplasms trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Completed Country / region: Brazil Clear all

175 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20023
20038
20045
20053
200613
20074
20088
200911
20107
20116
201215
201312
20148
201510
20167
20173
201810
20197
20207
20214
20224
20235
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed175

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche34
Novartis Pharmaceuticals19
AstraZeneca11
Eli Lilly and Company6
Pfizer6
Sanofi6
Instituto Nacional de Cancer, Brazil5
Latin American Cooperative Oncology Group5
University of Sao Paulo4
AC Camargo Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms175
Neoplasm Metastasis14
Neoplasms11
Fatigue5
Radiodermatitis5
Triple Negative Breast Neoplasms5
Lymphedema4
Pain4
Breast Diseases3
Neoplasms by Site3

Trials

Showing 1 to 25 of 175. Each trial links to its page on Pharma Observatory.

75 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.